Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

2016281 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 17, Issue 2, pp. 153-163

Field-Weighted Citation Impact: 30.73